Axon pathology in neurological disease: a neglected therapeutic target.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseasePotential therapeutic interest of adenosine A2A receptors in psychiatric disorders.A local mechanism mediates NAD-dependent protection of axon degenerationThe progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nervesSusceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosageNeuroprotective Transcription Factors in Animal Models of Parkinson DiseaseThe Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord InjuryStem cell autotomy and niche interaction in different systemsNeuronal endoplasmic reticulum stress in axon injury and neurodegenerationNeurotrauma and inflammation: CNS and PNS responsesNeuropathological alterations in Alzheimer diseaseAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionHuntingtin and its role in neuronal degenerationQuantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron culturesOxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammationEssential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degenerationMammalian sirtuins: biological insights and disease relevanceThe slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.Mechanisms of acute axonal degeneration in the optic nerve in vivo.Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location.A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degenerationProgressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's diseaseBrain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.Photoreceptor synapses degenerate early in experimental choroidal neovascularization.Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish.The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.Axonal transport plays a crucial role in mediating the axon-protective effects of NmNATIn vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegenerationClinical progression in Parkinson disease and the neurobiology of axons.Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.Diffusion tensor imaging, permanent pyramidal tract damage, and outcome in subcortical stroke.Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.Retrograde and Wallerian axonal degeneration occur synchronously after retinal ganglion cell axotomy.Bone marrow mesenchymal stem cells repair spinal cord ischemia/reperfusion injury by promoting axonal growth and anti-autophagy.Diapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss.Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis.Intracellular signalling pathways in dopamine cell death and axonal degeneration.WldS and PGC-1α regulate mitochondrial transport and oxidation state after axonal injury
P2860
Q21146752-95F10BDD-CA16-4ABB-94A8-236CCB1FAAC6Q24609725-C1E142BA-7956-4177-9E73-6C8FC9445428Q24657796-1DEB54EA-9E67-418B-9CA9-BB87E1630E75Q24679199-06118E74-A4F5-4EF5-9374-A31D15AA056CQ24806766-F37F8096-78A7-48B9-865A-5BA25E8B8464Q24811545-03ACB1E1-2FCC-43C9-A3DC-A04D16B6A114Q26765693-50F92A42-6F64-4BBA-B0D3-195AD6C7CBBBQ26767879-42F51A50-93EE-40D8-846E-7383FAED01D6Q26799282-65F98F16-EEAD-423F-BAB6-03DA25BF9D9FQ26826912-9FED46B5-6088-4F9B-AC90-365A2730C72DQ27001219-11357AF6-F53B-43D9-A39B-CB81C898C605Q27003314-04D7F78F-118D-412C-BCFF-DC28E8A5C68FQ27487496-283C2CEC-389E-48CB-8A65-8984F22D9F1AQ28281434-B3C352AD-B52B-4EC3-BEAC-E72F691BA099Q28364882-CC6CE2FF-7830-43E0-89A8-61E029B31E49Q28486241-B15DD78B-69F1-43CA-A749-79EA9F339506Q28509904-6151FA2C-186B-4FF3-A7C0-28259CCBDC3BQ29614496-634D1DFB-B3EA-4B77-BA54-B3B0B5DD6559Q30476859-6BC95559-AAF7-4BDC-9589-BE38DCDDC61CQ30494010-F70E9884-AFBD-44F5-B4CE-EDD15D1A8219Q30534999-DB51EA17-D036-49EF-8541-F68158884E3DQ30638030-0FCD53B4-9BDB-4D44-B1F8-B144B447ECB5Q30833636-8610A7FD-8158-4291-A139-B18D1247025DQ31070072-629DB2EF-73A5-4A0E-A693-D9524BCBEC7AQ33211350-E9994F7B-FA61-4DBD-9E80-BB5C195806A5Q33698363-08E27F19-282D-4063-8448-5278ABED8CBDQ33841702-3F839558-76B6-4E93-8A87-174FFDA8900DQ33932894-F095F01D-01A0-458A-A05D-6508DBD13CA5Q34050850-46A02848-3A31-4CED-9E72-C51B74F47878Q34052764-3951EC80-93C8-47BA-A2EB-EE686B9A3524Q34118301-E5F20D61-27D3-458B-8786-EC5552BE00F8Q34140388-CF0D2BDD-3E32-472E-AF4E-960AC0F67AFBQ34172960-C7687D65-F66E-4524-9CE4-FBDE5E5D64C3Q34285385-A4D54E4B-671F-4945-9353-00E3934A36E4Q34412723-0C3EAA6A-35BA-470D-8BB1-F56207E3EE63Q34539839-46A468E6-6B65-415D-A2CA-6379830438E8Q34579467-2660CE11-CA83-4803-AF49-F21F85366149Q34611758-6EAA9546-CC32-4067-81F8-B97994681886Q34936423-ACC138CA-F6A6-474A-BBF2-33BEC19C7A31Q34985546-C01A3594-5A4E-41C2-A167-625C051E7475
P2860
Axon pathology in neurological disease: a neglected therapeutic target.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Axon pathology in neurological disease: a neglected therapeutic target.
@ast
Axon pathology in neurological disease: a neglected therapeutic target.
@en
Axon pathology in neurological disease: a neglected therapeutic target.
@nl
type
label
Axon pathology in neurological disease: a neglected therapeutic target.
@ast
Axon pathology in neurological disease: a neglected therapeutic target.
@en
Axon pathology in neurological disease: a neglected therapeutic target.
@nl
prefLabel
Axon pathology in neurological disease: a neglected therapeutic target.
@ast
Axon pathology in neurological disease: a neglected therapeutic target.
@en
Axon pathology in neurological disease: a neglected therapeutic target.
@nl
P1476
Axon pathology in neurological disease: a neglected therapeutic target.
@en
P2093
Michael P Coleman
V Hugh Perry
P304
P356
10.1016/S0166-2236(02)02255-5
P577
2002-10-01T00:00:00Z